Across TCGA pan-cancer cohorts, LARP4P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LARP4P data layer.
The strongest signal is observed in mesothelioma (MESO), where higher LARP4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LARP4P expression acts as an unfavorable survival marker, although some lineages such as LUSC and UCS show a favorable association.
MESO, ACC, and KIRC are the cancer types where LARP4P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.